Goodpasture Syndrome Panel
Blood Sample
Free Home Collection
Digital Smart Report
Recommended for Male/Female
NABL & CAP Certified Labs
Trusted by Leading Doctors & Organizations
About Goodpasture Syndrome Panel
Goodpasture Syndrome Panel is a diagnostic test used to detect anti-glomerular basement membrane (anti-GBM) antibodies, which are associated with Goodpasture syndrome, a rare autoimmune disorder that affects the kidneys and lungs. The disease occurs when the immune system mistakenly produces antibodies that attack the basement membrane of the kidneys and lungs, leading to glomerulonephritis and pulmonary hemorrhage. Early detection of anti-GBM antibodies is crucial for initiating prompt treatment to prevent kidney failure and severe lung complications.
Goodpasture syndrome is an autoimmune disorder characterized by rapid and severe kidney damage (crescentic glomerulonephritis) and lung bleeding. The exact cause of the condition is unknown, but it is believed to result from a combination of genetic predisposition and environmental triggers, such as viral infections, smoking, and exposure to hydrocarbons or chemicals. The disease is more common in young males and older adults, with men being more affected than women. If left untreated, Goodpasture syndrome can progress rapidly to end-stage renal disease (ESRD) and life-threatening respiratory failure, making early diagnosis and treatment essential
What All Does This Test Measure?
The Goodpasture Syndrome Panel measures the presence and levels of specific antibodies that indicate an autoimmune attack on the glomerular basement membrane, including:
- Anti-GBM Antibodies: Detects autoantibodies attacking kidney and lung tissues.
- ANCA (Anti-Neutrophil Cytoplasmic Antibodies): Helps differentiate Goodpasture syndrome from other vasculitis conditions.
- Creatinine and Blood Urea Nitrogen (BUN): Assesses kidney function and potential renal impairment.
- Urinalysis: Detects blood and protein levels in urine, indicating kidney damage.
- Pulmonary Function Markers: Assesses lung involvement if respiratory symptoms are present.
What is the Goodpasture Syndrome Panel Used For?
This test is used to:
- Diagnose Goodpasture syndrome by detecting anti-GBM antibodies.
- Differentiate Goodpasture syndrome from other causes of glomerulonephritis and pulmonary bleeding.
- Monitor disease progression and response to treatment.
- Assess individuals with rapidly progressive glomerulonephritis (RPGN).
- Identify potential cases in high-risk individuals, such as those with autoimmune disorders.
Symptoms Indicating the Need for the Test
A healthcare provider may recommend this test if a patient presents with
-
Blood in urine (hematuria)
-
Decreased urine output
-
Swelling in legs and feet (edema)
-
Shortness of breath
-
Coughing up blood (hemoptysis)
-
Fatigue and weakness
Test preparation
No special preparation or fasting is required for this test.
A blood sample is collected from a vein in the arm.
Inform your doctor about any medications being taken, as certain drugs can affect test results.
Additional tests, such as kidney biopsy or urinalysis, may be required for a comprehensive diagnosis
Interpretation of the Test Results
Positive Result: Presence of anti-GBM antibodies, confirming Goodpasture syndrome.
Negative Result: No detectable antibodies, though further testing may be needed if symptoms persist.
Borderline Result: Repeat testing or additional diagnostic evaluations, such as ANCA testing, may be necessary
FAQs on Goodpasture Syndrome Panel
It is diagnosed through a combination of anti-GBM antibody testing, urinalysis, kidney biopsy, and imaging studies to assess lung and kidney involvement
While there is no cure, early treatment with plasmapheresis, corticosteroids, and immunosuppressive therapy can help manage symptoms and prevent severe complications
The exact cause is unknown, but it is believed to be triggered by genetic susceptibility, environmental factors, or viral infections
It is more common in young males and older adults, particularly those with a history of smoking or exposure to certain chemicals
Untreated cases can lead to kidney failure, severe lung damage, and potentially life-threatening complications
Goodpasture Syndrome Panel
